ATTENTION ALL CLASS MEMBERS: Please be advised that payments have been made to all authorized Claimants.
The information contained on this website is only a summary of the information presented in more detail in the Notice of (I) Pendency of Class Action and Approved Settlement; (II) Settlement Fairness Hearing; and (III) Motion for an Award of Attorneys’ Fees And Reimbursement Litigation Expenses. Because this website is just a summary, you should review the Notice for additional details.
Summary of the Action and Settlement
The Notice relates to an approved Settlement of claims in a securities class action brought by investors alleging, among other things, that defendant Zimmer Biomet Holdings, Inc. (“ZBH” or the “Company”), defendants David C. Dvorak, Daniel P. Florin, Robert J. Marshall Jr., Tony W. Collins (collectively the “Officer Defendants”), and defendants Christopher B. Begley, Betsy J. Bernard, Paul M. Bisaro, Gail K. Boudreaux, Michael J. Farrell, Larry Glasscock, Robert A. Hagemann, Arthur J. Higgins, Michael W. Michelson, Cecil B. Pickett, Ph.D., Jeffrey K. Rhodes (together with the Officer Defendants, “the Individual Defendants,” and, together with ZBH and the Officer Defendants, the “Defendants”) violated the federal securities laws by making false and misleading statements and failing to disclose material facts regarding ZBH during the Settlement Class Period. A more detailed description of the Action is set forth in paragraphs 11-26 of the Notice. The approved Settlement has settled claims of the Settlement Class.
The Court-appointed Lead Plaintiffs, Rajesh M. Shah and Matt Brierly (“Lead Plaintiffs”), and additional plaintiffs UFCW Local 1500 and Steven Castillo (together with Lead Plaintiffs, “Plaintiffs”), on behalf of themselves and the Settlement Class (as defined in paragraph 27 of the Notice), have reached an approved settlement of the Action for $50,000,000 in cash that has resolved all claims, whether known or unknown, in the Action (the “Settlement”).
The Settlement Class consists of:
all persons or entities who, between June 7, 2016 and November 7, 2016, inclusive, purchased or otherwise acquired ZBH Common Stock and/or Call Options, and/or wrote ZBH Put Options, and were damaged thereby.
Payments have been made to all eligible claimants.
How do I obtain more information?
More detailed information about the Action and the Settlement is contained in the Notice. If you have questions, you may contact the Claims Administrator by calling toll-free 1-888-670-1171; emailing info@ZimmerBiometSecuritiesLitigation.com; or mailing a letter to:
Shah et al. v.
Zimmer Biomet Holdings, Inc. et al.
c/o JND Legal Administration
P.O. Box 91367
Seattle, WA 98111
Inquiries should NOT be directed to the Court, the Clerk of the Court, Defendants, or their counsel.